Results for "HDA Factbook"
Transitioning COVID-19 Product Distribution to the Commercial Market
Throughout the COVID-19 pandemic, the federal government has primarily coordinated response efforts with the support of the private sector to develop, produce and distribute vaccines, personal protective equipment (PPE) and therapeutics. While this public health crisis continues, government and private-sector stakeholders are already thinking about the expected transition of COVID-19 product distribution to the commercial market — which could happen as early as the first quarter of this year.
Amid Segment Growth, Specialty Distributors Achieve High-Service Efficiencies, Enhanced Reliability
New benchmarking data released by the HDA Research Foundation illustrate the continued value of HDA specialty distributors to the U.S. healthcare ecosystem.
HDA Announces Chad Gielen and Kirk Kaminsky To Lead Board of Directors
HDA announced Chad Gielen, President/CEO of Louisiana Wholesale Drug Co. Inc., as Chairman of the HDA Board of Directors. Kirk Kaminsky, President, McKesson U.S. Pharmaceutical, will serve as Vice Chairman
HDA Statement on 2024 Presidential Election
HDA released a statement congratulating President-elect Donald J. Trump and Vice President-elect J.D. Vance on their victory in the presidential election.